These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 8408652

  • 1. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
    Meier CA, Parkison C, Chen A, Ashizawa K, Meier-Heusler SC, Muchmore P, Cheng SY, Weintraub BD.
    J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the thyroid hormone response element in the skeletal alpha-actin gene: negative regulation of T3 receptor binding by the retinoid X receptor.
    Muscat GE, Griggs R, Downes M, Emery J.
    Cell Growth Differ; 1993 Apr; 4(4):269-79. PubMed ID: 8388243
    [Abstract] [Full Text] [Related]

  • 3. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
    Piedrafita FJ, Ortiz MA, Pfahl M.
    Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
    [Abstract] [Full Text] [Related]

  • 4. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors.
    Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M.
    Nature; 1992 Jan 30; 355(6359):441-6. PubMed ID: 1310350
    [Abstract] [Full Text] [Related]

  • 5. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation.
    Shao ZM, Sheikh MS, Rishi AK, Dawson MI, Li XS, Wilber JF, Feng P, Fontana JA.
    Exp Cell Res; 1995 May 30; 218(1):1-8. PubMed ID: 7737350
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Periodically hyperthyroid phenotype in thyroid hormone resistance is associated with mutation D322N in the thyroid hormone receptor beta gene: transcriptional properties of the mutant and the role of retinoid X receptor.
    Behr M, Loos U.
    Exp Clin Endocrinol Diabetes; 1996 May 30; 104 Suppl 4():111-6. PubMed ID: 8981016
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD, Hsieh JC, Whitfield GK, Haussler CA, Jurutka PW, Galligan MA, Tillman JB, Spindler SR, Haussler MR.
    J Cell Biochem; 1999 Dec 01; 75(3):462-80. PubMed ID: 10536369
    [Abstract] [Full Text] [Related]

  • 9. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
    Meier-Heusler SC, Zhu X, Juge-Aubry C, Pernin A, Burger AG, Cheng SY, Meier CA.
    Mol Cell Endocrinol; 1995 Jan 01; 107(1):55-66. PubMed ID: 7796935
    [Abstract] [Full Text] [Related]

  • 10. Structural features of thyroid hormone response elements that increase susceptibility to inhibition by an RTH mutant thyroid hormone receptor.
    Zavacki AM, Harney JW, Brent GA, Larsen PR.
    Endocrinology; 1996 Jul 01; 137(7):2833-41. PubMed ID: 8770904
    [Abstract] [Full Text] [Related]

  • 11. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
    Zavacki AM, Harney JW, Brent GA, Larsen PR.
    Mol Endocrinol; 1993 Oct 01; 7(10):1319-30. PubMed ID: 8264663
    [Abstract] [Full Text] [Related]

  • 12. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.
    Zhu XG, McPhie P, Cheng SY.
    Endocrinology; 1997 Apr 01; 138(4):1456-63. PubMed ID: 9075702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L, Forrest D, Haugen BR, Wood WM, Curran T.
    Mol Endocrinol; 1995 Sep 01; 9(9):1202-13. PubMed ID: 7491112
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Second zinc finger mutants of thyroid hormone receptor selectively preserve DNA binding and heterodimerization but eliminate transcriptional activation.
    Nagaya T, Kopp P, Kitajima K, Jameson JL, Seo H.
    Biochem Biophys Res Commun; 1996 May 15; 222(2):524-30. PubMed ID: 8670238
    [Abstract] [Full Text] [Related]

  • 19. A mutant thyroid hormone receptor beta 1 identified in a patient with resistance to thyroid hormone inhibits the activities of not only the wild-type TRs, but also other nuclear receptors.
    Miyoshi Y, Nakao K.
    Biochem Biophys Res Commun; 1997 Sep 08; 238(1):39-43. PubMed ID: 9299447
    [Abstract] [Full Text] [Related]

  • 20. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.
    Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bercu BB.
    Mol Endocrinol; 1992 Feb 08; 6(2):248-58. PubMed ID: 1569968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.